Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Participants With High Lipoprotein(a)

Clinical trial NCT02160899 · COMPLETED

Trial details

NCT number: NCT02160899
Sponsor: Ionis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Elevated Lipoprotein(a)

Start date: 2014-06-01
Primary completion: 2015-11-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.